Time to approve glucagon-like peptide-1 receptor agonists for MASLD: a rational step based on robust evidence
- Abdelilah Arredouani*
*Corresponding author for this work
Research output: Contribution to journal › Letter › peer-review
Research output: Contribution to journal › Letter › peer-review